Paper8556494
Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes.
Bartlett MS and 6 others. Clin Diagn Lab Immunol, 1994. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes. Papers, record 8556494. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8556494
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Differentiation, T-Lymphocyte | Major topic |
| Dexamethasone | Major topic |
| Disease Models, Animal | Major topic |
| Pneumocystis | Major topic |
| Pneumonia, Pneumocystis | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| Evaluation Studies as Topic | |
| Female | |
| Immunosuppression Therapy | |
| Leukocyte Count | |
| Macrophages | |
| Mice | |
| Mice, Inbred BALB C | |
| Neutrophils |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3137861 | Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3137861 | PubMed |
| 2 | 1586713 | Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow. | Blood | 1992 | https://conductscience.org/library/papers/1586713 | PubMed |
| 3 | 2470952 | Identification of Pneumocystis carinii in immunodeficient mice. | Lab Anim Sci | 1989 | https://conductscience.org/library/papers/2470952 | PubMed |
| 4 | 2681438 | Prophylaxis of Pneumocystis carinii pneumonia: an update. | J Infect Dis | 1989 | https://conductscience.org/library/papers/2681438 | PubMed |
| 5 | 2574072 | Increased susceptibility to inoculated Lewis lung carcinoma (3LL) but unaltered tumor growth in mice treated with monoclonal antibody to L3T4 on mouse T-helper cells. | Cancer Invest | 1989 | https://conductscience.org/library/papers/2574072 | PubMed |
| 6 | 2295322 | Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.). | Exp Parasitol | 1990 | https://conductscience.org/library/papers/2295322 | PubMed |
| 7 | 2327770 | Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2327770 | PubMed |
| 8 | 2139668 | A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. | J Clin Invest | 1990 | https://conductscience.org/library/papers/2139668 | PubMed |
| 9 | 2117637 | Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. | J Exp Med | 1990 | https://conductscience.org/library/papers/2117637 | PubMed |
| 10 | 2393262 | Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2393262 | PubMed |
| 11 | 2178333 | Effect of rifabutin on disseminated Mycobacterium avium infections in thymectomized, CD4 T-cell-deficient mice. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2178333 | PubMed |
| 12 | 2024961 | 8-Aminoquinolines from Walter Reed Army Institute for Research for treatment and prophylaxis of Pneumocystis pneumonia in rat models. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/2024961 | PubMed |
| 13 | 1682252 | Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. | Infect Immun | 1991 | https://conductscience.org/library/papers/1682252 | PubMed |
| 14 | 1548065 | Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection. | Infect Immun | 1992 | https://conductscience.org/library/papers/1548065 | PubMed |
| 15 | 1548080 | Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals. | Infect Immun | 1992 | https://conductscience.org/library/papers/1548080 | PubMed |
| 16 | 1572137 | Inoculated mouse model of Pneumocystis carinii infection. | Diagn Microbiol Infect Dis | 1992 | https://conductscience.org/library/papers/1572137 | PubMed |
| 17 | 5297332 | Latent Pneumocystis infection of rats, relapse, and chemotherapy. | Lab Invest | 1966 | https://conductscience.org/library/papers/5297332 | PubMed |
| 18 | 4365115 | Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4365115 | PubMed |
| 19 | 305493 | Chronic fatal pneumocystosis in nude mice. | Jpn J Exp Med | 1977 | https://conductscience.org/library/papers/305493 | PubMed |
| 20 | 6174453 | Metabolic and synthetic activities of Pneumocystis carinii in vitro. | Infect Immun | 1981 | https://conductscience.org/library/papers/6174453 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26666941 | Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26666941 | PubMed |
| 15385471 | Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice. | Infect Immun | 2004 | https://conductscience.org/library/papers/15385471 | PubMed |
| 9916094 | Intranasal immunization confers protection against murine Pneumocystis carinii lung infection. | Infect Immun | 1999 | https://conductscience.org/library/papers/9916094 | PubMed |
| 9593116 | Prevention of infection due to Pneumocystis carinii. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9593116 | PubMed |
| 9455884 | Antibody to Pneumocystis carinii protects rats and mice from developing pneumonia. | Clin Diagn Lab Immunol | 1998 | https://conductscience.org/library/papers/9455884 | PubMed |
| 8843286 | Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8843286 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8556494
GET https://conductscience.org/api/papers/v1/8556494/references?page=2